Breaking News
Winter Is Coming: Europe Faces Twin Diesel And NatGas Crunch
Islamic Society Sues City Over Rejection Of Mosque Proposal
Wall Street Crowns First Solar As Clear Winner After Trump's Polysilicon Tariffs Create...
US Senate Pushes CLARITY Act Vote To September
Top Tech News
What could possibly go wrong? Scientists use AI to design new viruses
Dual-motor suitcase drive underpins 3,000-hp hypercar
DoorDash Wins Federal Approval To Fly Its Own Delivery Drones
Shade-Resistant Solar Cells Retain 97% Efficiency After 2,000 Hours of Testing
20 Ancient Engineering SECRETS
Stonehenge Was Reanalyzed by AI -- And the Findings Are Hard to Explain
After Years Of Delays, Aptera Is Finally Preparing To Build Customer Cars
'When you kill it, it doesn't die': the jellyfish that has cracked the secret of immorta
Archer Aviation debuts Halo autonomous VTOL, Thunder's commercial twin
US Telecoms Slide On Starlink Mobile Threat; Bernstein Sees It As A "Jab, But No Knockout Yet**
The FDA Just Expanded Access to MDMA as a Therapy for PTSD
The U.S. Food and Drug Administration just made it a lot easier for patients with hard-to-treat post-traumatic stress disorder to use MDMA, a popular rave drug, to treat their condition. Under an FDA program known as Expanded Access, 10 sites across the nation can apply for approval to administer the drug under a doctor's supervision. Just 50 patients will be enrolled, but it could open the door to wider availability of MDMA and give real-world evidence that the drug works as effectively as studies suggest.